Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Mitomycin × Gastrointestinal × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 52 NIH 8 NETWORK 8 UNKNOWN 1 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Oxaliplatin 29 Capecitabine 26 Irinotecan 19 Fluorouracil 19 tislelizumab 18 apatinib 14 Paclitaxel 13 Cisplatin 13 S 1 (combination) 12 Radiotherapy 12 Bevacizumab 11 Leucovorin 10 Laparoscopy 9 Cetuximab 9 sintilimab 8 Endoscopic Mucosal Resection 8 Drug Therapy 8 Gemcitabine 7 Docetaxel 7 XELOX 6 Radiation 6 Propranolol 6 Nivolumab 6 Neoadjuvant Therapy 6 Immune Checkpoint Inhibitors 6 Folfox protocol 6 camrelizumab 5 Surgical Procedures, Operative 5 Levoleucovorin 5 HMPL-013 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06233877 2024-02-28

GFLIPM

Hirschfeld Oncology

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡